APA
Lewis M. D., Horan M., Millar D. S., Newsway V., Easter T. E., Fryklund L., Gregory J. W., Norin M., Del Valle C., López-Siguero J. P., Cañete R., López-Canti L. F., Díaz-Torrado N., Espino R., Ulied A., Scanlon M. F., Procter A. M. & Cooper D. N. (20040402). A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. : The Journal of clinical endocrinology and metabolism.
Chicago
Lewis Mark D, Horan Martin, Millar David S, Newsway Vicky, Easter Tammy E, Fryklund Linda, Gregory John W, Norin Martin, Del Valle Cristóbal-Jorge, López-Siguero Juan Pedro, Cañete Ramón, López-Canti Luis Fernando, Díaz-Torrado Nieves, Espino Rafael, Ulied Angels, Scanlon Maurice F, Procter Annie M and Cooper David N. 20040402. A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. : The Journal of clinical endocrinology and metabolism.
Harvard
Lewis M. D., Horan M., Millar D. S., Newsway V., Easter T. E., Fryklund L., Gregory J. W., Norin M., Del Valle C., López-Siguero J. P., Cañete R., López-Canti L. F., Díaz-Torrado N., Espino R., Ulied A., Scanlon M. F., Procter A. M. and Cooper D. N. (20040402). A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. : The Journal of clinical endocrinology and metabolism.
MLA
Lewis Mark D, Horan Martin, Millar David S, Newsway Vicky, Easter Tammy E, Fryklund Linda, Gregory John W, Norin Martin, Del Valle Cristóbal-Jorge, López-Siguero Juan Pedro, Cañete Ramón, López-Canti Luis Fernando, Díaz-Torrado Nieves, Espino Rafael, Ulied Angels, Scanlon Maurice F, Procter Annie M and Cooper David N. A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. : The Journal of clinical endocrinology and metabolism. 20040402.